1. Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936
- Author
-
David C. Page, Alan J. Gow, Ian J. Deary, Olivia K.L. Hamilton, M. del C. Valdés-Hernández, Paul Redmond, Simon R. Cox, Joanna M. Wardlaw, Adele M. Taylor, Lucia Ballerini, Janie Corley, Mark E. Bastin, S. Muñoz Maniega, F. Conte, Judith A. Okely, Hamilton, O, Cox, S, Okely, J, Conte, F, Ballerini, L, Bastin, M, Corley, J, Taylor, A, Page, D, Gow, A, Munoz Maniega, S, Redmond, P, Valdes-Hernandez, M, Wardlaw, J, and Deary, I
- Subjects
Male ,0301 basic medicine ,Context (language use) ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Disease ,Predictive markers ,M-PSI/02 - PSICOBIOLOGIA E PSICOLOGIA FISIOLOGICA ,Article ,Learning and memory ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Cognition ,0302 clinical medicine ,Memory ,Covariate ,Humans ,Medicine ,Cognitive Dysfunction ,Cognitive decline ,Child ,Association (psychology) ,Biological Psychiatry ,Disease burden ,Aged ,Aged, 80 and over ,business.industry ,Cerebral Small Vessel Disease ,Magnetic Resonance Imaging ,Psychiatry and Mental health ,030104 developmental biology ,Cerebral Small Vessel Diseases ,Female ,Verbal memory ,business ,Birth cohort ,030217 neurology & neurosurgery ,Demography ,RC321-571 - Abstract
Slowed processing speed is considered a hallmark feature of cognitive decline in cerebral small vessel disease (SVD); however, it is unclear whether SVD’s association with slowed processing might be due to its association with overall declining general cognitive ability. We quantified the total MRI-visible SVD burden of 540 members of the Lothian Birth Cohort 1936 (age: 72.6 ± 0.7 years; 47% female). Using latent growth curve modelling, we tested associations between total SVD burden at mean age 73 and changes in general cognitive ability, processing speed, verbal memory and visuospatial ability, measured at age 73, 76, 79 and 82. Covariates included age, sex, vascular risk and childhood cognitive ability. In the fully adjusted models, greater SVD burden was associated with greater declines in general cognitive ability (standardised β: −0.201; 95% CI: [−0.36, −0.04]; pFDR = 0.022) and processing speed (−0.222; [−0.40, −0.04]; pFDR = 0.022). SVD burden accounted for between 4 and 5% of variance in declines of general cognitive ability and processing speed. After accounting for the covariance between tests of processing speed and general cognitive ability, only SVD’s association with greater decline in general cognitive ability remained significant, prior to FDR correction (−0.222; [−0.39, −0.06]; p = 0.008; pFDR = 0.085). Our findings do not support the notion that SVD has a specific association with declining processing speed, independent of decline in general cognitive ability (which captures the variance shared across domains of cognitive ability). The association between SVD burden and declining general cognitive ability supports the notion of SVD as a diffuse, whole-brain disease and suggests that trials monitoring SVD-related cognitive changes should consider domain-specific changes in the context of overall, general cognitive decline.
- Published
- 2021